Avisa Diagnostics Inc.
Other OTCTotal Valuation
Avisa Diagnostics Inc. carries a market capitalization of 97,176.00, placing it among publicly traded companies globally. Its enterprise value stands at 4.48M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 97,176.00 |
| Enterprise Value | 4.48M |
Share Statistics
Avisa Diagnostics Inc. currently has 2.75M shares outstanding.
| Shares Outstanding | 2.75M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Avisa Diagnostics Inc. trades at a trailing price-to-earnings ratio of 2.26.
| PE Ratio | 2.26 |
| PS Ratio | N/A |
| PB Ratio | -1.18 |
| P/TBV Ratio | -4.67 |
| P/FCF Ratio | -3.88 |
| P/OCF Ratio | -3.88 |
Financial Position
Avisa Diagnostics Inc. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -112.92, indicating conservative leverage, while an interest coverage ratio of -10.90 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.06 |
| Quick Ratio | 0.04 |
| Debt / Equity | -112.92 |
| Debt / EBITDA | -0.18 |
| Interest Coverage | -10.90 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -227.24 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -10.39 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Income Statement
EBITDA reached -5.01M, while operating income came in at -5.03M.
| Revenue | N/A |
| Gross Profit | -1,371.00 |
| Operating Income | -5.03M |
| Pretax Income | -3.57M |
| Net Income | -3.57M |
| EBITDA | -5.01M |
| EBIT | -5.03M |
| Earnings Per Share (EPS) | -0.30 |
Balance Sheet
Avisa Diagnostics Inc. holds 97,601.00 in cash and equivalents against 891,409.00 in total debt, resulting in a net debt position of 600,364.00. Total book value stands at -3.13M, with working capital of -2.57M providing operational flexibility.
| Cash & Cash Equivalents | 97,601.00 |
| Total Debt | 891,409.00 |
| Net Debt | 600,364.00 |
| Equity (Book Value) | -3.13M |
| Book Value Per Share | -0.26 |
| Working Capital | -2.57M |
Cash Flow
Avisa Diagnostics Inc. produced -951,570.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -951,570.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -951,570.00 |
| FCF Per Share | -0.08 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 16.53 |
| FCF Yield | -25.79 |
Stock Splits
Avisa Diagnostics Inc.'s most recent stock split took place on May 18, 2021 with a 15:1 split ratio.
| Last Split Date | 5/18/2021 |
| Split Ratio | 15:1 |
Scores
Avisa Diagnostics Inc. posts an Altman Z-Score of -21.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -21.61 |